This clinical trial is focused on studying the effects of two medications, Ropivacaine and Lidocaine, used as local anesthesia for patients undergoing surgery to remove their tonsils, a procedure known as a tonsillectomy. The study is particularly interested in patients who have Chronic Tonsillitis, which is a persistent inflammation of the tonsils. The main goal of the study is to determine if Ropivacaine is more effective than Lidocaine in reducing pain after the surgery.
Participants in the study will receive either Ropivacaine or Lidocaine during their tonsillectomy. The study will monitor the level of pain experienced by participants after the surgery using a tool called the Visual Analog Scale, which measures pain on a scale from 0 to 10. This will be done several times a day for the first three days after the surgery. The study will also look at how much pain medication participants need during their hospital stay and how quickly they need additional pain relief after the surgery.
The trial will last until the end of 2025, with recruitment of participants expected to start in mid-2025. The study aims to provide valuable information on which local anesthetic is more effective in managing pain after a tonsillectomy, potentially improving recovery experiences for patients with Chronic Tonsillitis.



Austria